Ginkgo Biloba and Parkinson's Disease: Latest Research 2026

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Ginkgo Biloba and Parkinson's Disease: Latest Research 2026

This page summarizes the current state of scientific research on Ginkgo Biloba in the context of Parkinson's Disease as of 2026. The field evolves rapidly — this is a research summary, not medical advice. Consult your neurologist or movement disorder specialist for personalized guidance.

Compound Overview

Ginkgo Biloba (Herbal / Nootropic) — Dietary supplement; not FDA-approved

Mechanism of action: Platelet activating factor inhibition; improves cerebrovascular circulation; antioxidant flavonoids; neuroprotective

Current evidence level: Mixed RCT evidence for dementia prevention; some positive cognitive studies; negative GEM trial

2026 Research Landscape

Research has directly examined Ginkgo Biloba in Parkinson's, making this a field with active scientific interest.

Key areas researchers are currently examining include:

  • Mechanistic studies: Understanding precisely how Ginkgo Biloba affects the biological pathways involved in Parkinson's Disease progression
  • Safety characterization: Defining appropriate doses and monitoring protocols if clinical use is considered
  • Biomarker identification: Finding measurable indicators that could predict which patients might respond
  • Clinical trials: Phase I/II investigations examining Ginkgo Biloba in Parkinson's patients are ongoing or recently completed

Where to Find the Most Current Research

To access the latest peer-reviewed publications:

  • PubMed: Search "(Ginkgo Biloba[tiab]) AND (Parkinson's Disease[tiab])" at pubmed.ncbi.nlm.nih.gov
  • ClinicalTrials.gov: Search for active and completed trials with Ginkgo Biloba keywords
  • Google Scholar: Sort by date for most recent publications

Research Gaps

The most significant gaps in the Ginkgo Biloba + Parkinson's research landscape as of 2026 include: lack of large Phase III randomized trials, limited long-term safety data in Parkinson's patients, and absence of biomarker-selected patient populations who might benefit most.

Medical Disclaimer: This page summarizes published research and is not medical advice. Never start, stop, or change any treatment based on information found online. Always consult qualified healthcare professionals before making treatment decisions.

Get a personalized AI-generated research report at insightswarm.ai.

Frequently Asked Questions

What are the most recent studies on Ginkgo Biloba for Parkinson's?

The most current peer-reviewed studies can be found on PubMed (pubmed.ncbi.nlm.nih.gov). Search for 'Ginkgo Biloba Parkinson's Disease' filtered to the last 2 years. The current evidence level is: Mixed RCT evidence for dementia prevention; some positive cognitive studies; negative GEM trial.

Are there any 2025-2026 clinical trials for Ginkgo Biloba in Parkinson's?

Check ClinicalTrials.gov with 'Ginkgo Biloba' as intervention and 'Parkinson's Disease' as condition. Filter by 'Recruiting' status for currently enrolling trials. Your neurologist or movement disorder specialist can advise whether any trials may be appropriate for your specific situation.

Has the evidence for Ginkgo Biloba in Parkinson's changed recently?

The field evolves rapidly. The current evidence classification is: Mixed RCT evidence for dementia prevention; some positive cognitive studies; negative GEM trial. For the most up-to-date summary, Insight Swarm generates personalized research reports that incorporate the latest publications specific to your case.